Semaglutide

Semaglutide is a glucagon-like peptide-1 receptor (GLP-1) agonist, that helps your pancreas release insulin to decrease blood sugar levels which promotes weight loss. This is done by activating a blood-sugar regulating protein found within the beta cells of your pancreas. It delays stomach emptying leading to a feeling of fullness & satisfaction, and slows intestinal motility. Studies1 have shown that 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.1 Participates are showing real results with an average of 12-15lbs loss per month!

​

In a semaglutide weight loss trial2 that included almost 2000 adults with BMIs of 30 and greater, more than half of the participants lost 15% of their body weight. Most of the participants lost at least 10% of their body weight. The participants were not diabetic indicating semaglutide is beneficial for weight loss in non-diabetic persons. Also, the participants taking semaglutide showed improvements in blood pressure, blood sugar, and heart disease risk.

​

References:

1. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014

2. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183